the cancer collaborative


come on in

bridging science, policy and advocacy

how we’re different  the cancer collaborative is a hub for the cancer community. created to foster an environment of collaboration amongst science, policy and advocacy in order to make a meaningful contribution to cancer care.  our goal is to co-create and collaborate with stakeholders to proactively identify the challenges and opportunities, prioritize them and work together to make action-oriented changes on how cancer care is delivered in canada and beyond. better outcomes for cancer patients in canada can only be achieved when we let go of old ideologies- embracing innovation, encouraging collaboration, creating collective purpose and fundamentally changing. bold ideas and fuelling dialogues that adapt and adopt to shifting paradigms.

we can be the catalyst for change



car-t cell therapy


accelerating adoption through collaboration

car-t cell therapy has entered clinical practice.  such a paradigm-shifting and novel cancer therapy that relies on viral production, genetic- modification, cell expansion, quality control/quality analysis, as well as clinical application and toxicity management poses significant challenges to regulatory and reimbursement approval.  .

expanding access to create sustainability

biosimilar medicines represent a rapidly emerging field that can offer improved accessibility to medicines for patients at reduced expenditure for healthcare systems that are tackling issues of sustainability. the next two years will be important for biosimilars uptake and impact.  biosimilars uptake in oncology can positively impact the financial burden of healthcare systems with the cost savings being reallocated to improve overall health system outcomes, globally.

personalised medicine


cracking the cancer code

personalized medicine and biomarkers present an incredible opportunity to revolutionize health care. it has the potential to change the way we think about, identify and manage cancer care. the impact on both clinical research and patient care will grow as our understanding and technologies improve transforming the delivery of cancer care to benefit both patients and cancer care systems.

tipping pIOnt

immuno-oncology [IO] therapies continue to create breakthroughs however real world challenges and significant shifts in value across healthcare systems create barriers to access for patients.

                        managing innovation in oncology

                            capacity building

catalysts for change in cancer care

the next decade in healthcare will look nothing like the last- oncology is experiencing a tidal wave of therapies and technologies that continues to profoundly change the way cancer is diagnosed, treated, and monitored. the arrival of novel and disruptive technologies, precision medicine and emerging technologies, will drive oncology onward and the decisions taken today will have an impact on the landscape over the next decade.  industry, regulators, HTA, pricing agencies, health care professionals, researchers and patient advocates must work together to address these challenges and create solutions to overcome these clinical, regulatory, reimbursement and policy hurdles.

building better advocates

the cancer collaborative considers advocacy an important tool in improving cancer care at provincial, national and global levels and patient advocates who are well informed and who have a thorough understanding of the clinical and political landscape can better identify, shape and influence policy and develop effective advocacy strategies and communication with decision makers. strengthening their capacity to address québec specific challenges and opportunities, and to better understand, respond and engage within the pan-canadian environment to proactively engage in an effective and efficient manner.




our BLOG

COVID 19 resources for cancer

colab would like to express its deep gratitude for the healthcare workers across the world who under the most extraordinary circumstances continue to work tirelessly to keep us all safe. in times like this it is important to keep the flow of information, colab...



Get our latest colab notebooks and briefs –>  MORE